Receptos LLC
(UNKNOWN : RCPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc.
0.06%69.202.3%$1202.11m
PFEPfizer Inc.
0.32%42.990.9%$972.86m
JNJJohnson & Johnson
-0.49%131.850.7%$941.27m
MRKMerck & Co., Inc.
0.16%81.720.6%$784.02m
BMYBristol-Myers Squibb Company
-0.61%44.181.4%$644.57m
LLYEli Lilly and Company
-0.22%108.591.0%$345.47m
NVSNovartis AG Sponsored ADR
1.76%90.730.2%$146.74m
GSKGlaxoSmithKline plc Sponsored ADR
-0.10%41.140.2%$93.83m
AZNAstraZeneca PLC Sponsored ADR
0.37%40.351.2%$89.57m
SNYSanofi Sponsored ADR
-0.36%41.680.2%$70.60m
NVONovo Nordisk A/S Sponsored ADR Class B
1.01%48.200.1%$67.04m
LCILannett Company, Inc.
-3.03%5.6036.6%$4.06m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%1.871.6%$0.27m
EPIXESSA Pharma Inc
0.67%3.010.1%$0.01m

Company Profile

Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in Delaware.